Filter Results:
(373)
Show Results For
- All HBS Web
(373)
- News (76)
- Research (279)
- Events (9)
- Multimedia (1)
- Faculty Publications (137)
Show Results For
- All HBS Web
(373)
- News (76)
- Research (279)
- Events (9)
- Multimedia (1)
- Faculty Publications (137)
- 01 Dec 2010
- News
Chaotic Funding Derails Research
randomized model of research support in the United States, in which a change in administration or a court ruling can outlaw work that was previously supported by the government. Funding can be canceled with the stroke of a pen. The... View Details
- 15 Aug 2024
- Op-Ed
Post-CrowdStrike, Six Questions to Test Your Company's Operational Resilience
team. Incorporate unanticipated, random complications and consider scheduling exercises during peak and non-peak business hours. Ensure the dissemination of clear crisis management procedures to provide structured and effective responses... View Details
Keywords: by Hise Gibson and Anita Lynch
- February 2013
- Article
An Activity-Generating Theory of Regulation
By: Joshua Schwartzstein and Andrei Shleifer
We propose an activity-generating theory of regulation. When courts make errors, tort litigation becomes unpredictable and as such imposes risk on firms, thereby discouraging entry, innovation, and other socially desirable activity. When social returns to activity are... View Details
Keywords: Courts and Trials; Lawsuits and Litigation; Governing Rules, Regulations, and Reforms; Theory
Schwartzstein, Joshua, and Andrei Shleifer. "An Activity-Generating Theory of Regulation." Journal of Law & Economics 56, no. 1 (February 2013): 1–38. (Lead Article.)
- June 2023 (Revised July 2024)
- Case
Biogen and the Aduhelm Melee
By: Amitabh Chandra and Lauren Gunasti
Alzheimer's Disease is a devastating condition affecting millions of Americans. At this time, there is no cure. In 2021, Biogen's Aduhelm (aducanumab) received FDA approval under the accelerated approval pathway after a controversial approval process.
This... View Details
This... View Details
Keywords: Health Testing and Trials; Governing Rules, Regulations, and Reforms; Valuation; Product Development; Pharmaceutical Industry
Chandra, Amitabh, and Lauren Gunasti. "Biogen and the Aduhelm Melee." Harvard Business School Case 623-046, June 2023. (Revised July 2024.)
- 21 Jul 2006
- Op-Ed
Enron Jury Sent the Right Message
The most noteworthy message of the Enron trial is that corporate executives can be convicted in a court of law for a pattern of deception that may or may not be illegal. Left unaddressed in the trial were... View Details
Keywords: by Malcolm S. Salter
- 30 Jan 2012
- Research & Ideas
Measuring the Efficacy of the World’s Managers
larger number of organizations. The researchers have also started to work on management experiments, modeled on the randomized control trials adopted in the medical field. This... View Details
Keywords: by Carmen Nobel
- 09 Feb 2010
- First Look
First Look: Feb. 9
both proprietary and shared platforms toward hybrid governance models characterized by centralized control over platform technology (i.e., closed sponsorship) and shared responsibility for serving users (i.e., an open provider role).... View Details
Keywords: Martha Lagace
- 30 Dec 2013
- Research & Ideas
Most Popular Articles of 2013
alleviate congestion, and can actually increase it. Research by Jillian Berry Jaeker, Anita L. Tucker, and Michael H. Lee. Applying Random Coefficient Models to Strategy Research: Testing For Firm Heterogeneity, Predicting Firm-Specific... View Details
Keywords: by Staff
- 10 Nov 2015
- First Look
November 10, 2015
communication and collaboration between practitioners and academics by introducing key vocabulary and concepts used in rigorous impact evaluation methods, starting with randomized controlled View Details
Keywords: Sean Silverthorne
- 2010
- Chapter
From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance
By: Arthur A. Daemmrich
Adverse drug reactions pose distinct but potentially catastrophic risks to patients, physicians, pharmaceutical firms, and regulators. Between the early 1960s and the present, national systems were built to collect, standardize, and respond to individual reports of... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Testing and Trials; Business and Government Relations; Risk and Uncertainty; Safety; Pharmaceutical Industry; United States
Daemmrich, Arthur A. "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance." Chap. 13 in The Fragmentation of U.S. Health Care: Causes and Solutions, edited by Einer Elhauge, 301–322. Oxford: Oxford University Press, 2010.
- 25 Feb 2020
- News
Alumni and Faculty Books for March 2020
impact of changes to an experience or product. Once an esoteric tool for academic research, the randomized controlled trial has gone mainstream—and is becoming an important... View Details
- 21 Aug 2012
- Research & Ideas
How to Sink a Startup
Tim Westergren of Pandora and Evan Williams of Twitter. YouTube cofounder and former CEO Chad Hurley has called the book "an invaluable alternative to real-world trial and error." A past recipient of the HBS student-voted award for... View Details
Keywords: by Garry Emmons
- 24 Jul 2019
- Lessons from the Classroom
Can These Business Students Motivate Londoners to Do the Right Thing?
unintended consequences..." The approach has really taken hold in policy settings, and there are now many teams in governments focused on bringing behavioral insights and randomized controlled View Details
Keywords: by Dina Gerdeman
- 02 Jan 2019
- What Do You Think?
SUMMING UP: Do We Need an Artificial Intelligence Czar?
such a person might be needed. Does the United States need an artificial intelligence czar? What do you think? References: David Ignatius, China’s application of AI should be a Sputnik moment for the U.S. But will it be?, The Washington Post, November 6, 2018. Steven... View Details
- 05 Nov 2024
- Research & Ideas
AI Can Help Leaders Communicate, But Can't Make Employees Listen
London’s School of Management, and Amirhossein Zohrehvand, assistant professor at Leiden University. Turing, meet Wade The Turing Test is an imitation game in which a person must guess whether they’re communicating with a machine or another person; if their success... View Details
- 17 Mar 2009
- First Look
First Look: March 17, 2009
Microfinance in particular has often been argued, but not without controversy, to be a tool for empowering women. Here, using a randomized controlled trial, we examine whether access to, and marketing of, an... View Details
Keywords: Martha Lagace
- 01 Mar 2016
- News
Off Script
control. They also control health funding deficits by encouraging, or even requiring, their main populations to aggressively set aside medical savings during their earning years to help with older age health care. Such actions are much... View Details
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
Abstract—Objective: Assess whether a commitment contract informed by behavioral economics leads to persistent virologic suppression among HIV-positive patients with poor antiretroviral therapy (ART) adherence. Design: Single-center pilot View Details
Keywords: Sean Silverthorne
- 02 Nov 2010
- First Look
First Look: November 2, 2010
perceived agreeableness; the decrease in leadership effectiveness perception between moderate and high decision latitude was explained by a decrease in perceived conscientiousness. Theoretical and practical implications of these findings are discussed. Keeping the... View Details
Keywords: Sean Silverthorne
- 01 Jun 2012
- News
Pitfalls, Trade-Offs, Dreaming Big
entrepreneurs such as Tim Westergren of Pandora and Evan Williams of Twitter. YouTube cofounder and former CEO Chad Hurley has called the book “an invaluable alternative to real-world trial and error.” A past recipient of the HBS... View Details